methylation-specific PCR
Previse Awarded $1.8M NIH Grant to Develop Esophageal Cancer Test
The Maryland-based firm said that the money will support the development and commercialization of a screening test for esophageal squamous cell carcinoma.
Previse Completes Validation Study of Barrett's Esophagus Test, Sees Path to Guideline Inclusion
Premium
The epigenetic risk stratification test demonstrated the potential to decrease surveillance among some patients and increase it among others.
Company researchers have shown that EpiDirect can detect and quantify 5mC without bisulfite treatment, demonstrating it on a promoter in human brain tumor samples.
Through a US-based subsidiary, the South Korean firm has received breakthrough device designation for its bladder cancer test that could accelerate it to market.
Inex Innovate to Launch PCR-Based Endometrial Cancer Detection Test
The Singapore-based company plans to launch the epiHera test in August, following interim results from a clinical study with researchers at the Chinese University of Hong Kong.